![La Gazette du Laboratorie](https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/966/normal/Screen_Shot_2016-02-02_at_16.32.21.png?1454430756)
La Gazette du LABORATOIRE Brèves
La Gazette du Laboratorie,
2021-06-18 Thérapie cellulaire CAR T : Nouvelles données de l’essai ZUMA-3 dans la leucémie aigüe lymphoblastique /GILEAD …
2021-06-18 Thérapie cellulaire CAR T : Nouvelles données de l’essai ZUMA-3 dans la leucémie aigüe lymphoblastique /GILEAD …
BLINCYTO is the First-and-Only Bispecific CD19-Directed CD3 T-Cell Engager (BiTE ® ) Immunotherapy Approved by Health Canada…
THOUSAND OAKS, Calif., Sept. 25, 2015 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the Committee for Medicinal…
THOUSAND OAKS, Calif., Sept. 25, 2015 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the Committee for Medicinal…
THOUSAND OAKS, Calif., Sept. 25, 2015 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the Committee for Medicinal…